Silexion Therapeutics Corp
SLXN · XNASCIK 2022416fmd_1EC25RB7AFASA7JMB5ZMH6G2QNManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2023 to Sep 30, 2026, 14 periods
News summary
An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.
AI-written
0 filings
From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).
Loading